Pharmaceuticals

The pharmaceutical industry is a EUR 1 trillion sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.
Page 1/16
Category Tools

Biotechnology in Japan

August 2013 · MarketLine Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Australia

August 2013 · MarketLine OTC Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Biotechnology in the United Kingdom

August 2013 · MarketLine Biotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in South Africa

August 2013 · MarketLine OTC Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in United Arab Emirates

August 2013 · MarketLine OTC Pharmaceuticals in United Arab Emirates industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in Asia-Pacific

August 2013 · MarketLine Generics in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

Global OTC Pharmaceuticals

August 2013 · MarketLine Global OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in China

August 2013 · MarketLine Generics in China industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in Germany

August 2013 · MarketLine Generics in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Canada

August 2013 · MarketLine OTC Pharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in Spain

August 2013 · MarketLine Generics in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in France

August 2013 · MarketLine OTC Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Spain

August 2013 · MarketLine OTC Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Singapore

August 2013 · MarketLine OTC Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Japan

August 2013 · MarketLine OTC Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in India

August 2013 · MarketLine OTC Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Biotechnology in Asia-Pacific

August 2013 · MarketLine Biotechnology in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00

Biotechnology in China

August 2013 · MarketLine Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Russia

August 2013 · MarketLine OTC Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Biotechnology in Germany

August 2013 · MarketLine Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Norway

August 2013 · MarketLine OTC Pharmaceuticals in Norway industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Biotechnology in Spain

August 2013 · MarketLine Biotechnology in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Taiwan

August 2013 · MarketLine OTC Pharmaceuticals in Taiwan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Biotechnology in the United States

August 2013 · MarketLine Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Switzerland

August 2013 · MarketLine OTC Pharmaceuticals in Switzerland industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in Belgium

August 2013 · MarketLine Generics in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Asia-Pacific

August 2013 · MarketLine OTC Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in Europe

August 2013 · MarketLine Generics in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in Italy

August 2013 · MarketLine Generics in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in China

August 2013 · MarketLine OTC Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in the Netherlands

August 2013 · MarketLine Generics in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Germany

August 2013 · MarketLine OTC Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in the Netherlands

August 2013 · MarketLine OTC Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Mexico

August 2013 · MarketLine OTC Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Biotechnology in Belgium

August 2013 · MarketLine Biotechnology in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Hungary

August 2013 · MarketLine OTC Pharmaceuticals in Hungary industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Biotechnology in Europe

August 2013 · MarketLine Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in the Czech Republic

August 2013 · MarketLine OTC Pharmaceuticals in the Czech Republic industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Biotechnology in Italy

August 2013 · MarketLine Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00

Generics in the United States

August 2013 · MarketLine Generics in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2007-11, and forecast to 2016). € 259,00

OTC Pharmaceuticals in Sweden

August 2013 · MarketLine OTC Pharmaceuticals in Sweden industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Biotechnology in the Netherlands

August 2013 · MarketLine Biotechnology in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in South Korea

August 2013 · MarketLine OTC Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Saudi Arabia

August 2013 · MarketLine OTC Pharmaceuticals in Saudi Arabia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Global Generics

August 2013 · MarketLine Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in the United Kingdom

August 2013 · MarketLine OTC Pharmaceuticals in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in Canada

August 2013 · MarketLine Generics in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

OTC Pharmaceuticals in Belgium

August 2013 · MarketLine OTC Pharmaceuticals in Belgium industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in France

August 2013 · MarketLine Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00

Generics in Japan

August 2013 · MarketLine Generics in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). € 259,00
Options